本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcus Biosciences Inc.

24.22
+3.8518.90%
成交量:210.50万
成交额:4,871.23万
市值:30.36亿
市盈率:-7.36
高:24.71
开:20.37
低:20.29
收:20.37
52周最高:26.40
52周最低:6.50
股本:1.25亿
流通股本:8,865.18万
量比:2.21
换手率:2.37%
股息:- -
股息率:- -
每股收益(TTM):-3.2900
每股收益(LYR):-3.2900
净资产收益率:-63.26%
总资产收益率:-21.08%
市净率:4.81
市盈率(LYR):-7.36

数据加载中...

2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

重要事件披露

Form 8-K - Current report
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

重要事件披露

Form 8-K - Current report